Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1976 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Shrita Sarkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Nanomedicine, Neoplastic Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine.
Abstract (Originalsprache)
The recurrent nature of glioblastoma negatively impacts conventional treatment strategies leading to a growing need for nanomedicine. Nanotherapeutics, an approach designed to deliver drugs to specific sites, is experiencing rapid growth and gaining immense popularity. Having potential in reaching the hard‐to‐reach disease sites, this field has the potential to show high efficacy in combatting glioblastoma progression. The presence of glioblastoma stem cells (GSCs) is a major factor behind the poor prognosis of glioblastoma multiforme (GBM). Stemness potential, heterogeneity, and self‐renewal capacity, are some of the properties that make GSCs invade across the distant regions of the brain. Despite advances in medical technology and MRI‐guided maximal surgical resection, not all GSCs residing in the brain can be removed, leading to recurrent disease. The aggressiveness of GBM is often correlated with immune suppression, where the T‐cells are unable to infiltrate the cancer initiating GSCs. Standard of care therapies, including surgery and chemotherapy in combination with radiation therapy, have failed to tackle all the challenges of the GSCs, making it increasingly important for researchers to develop strategies to tackle their growth and proliferation and reduce the recurrence of GBM. Here, we will focus on the advancements in the field of nanomedicine that has the potential to show positive impact in managing glioblastoma tumor microenvironment. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, Florida, USA.
- Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Department of Immunology and Nano-Medicine, Herbert Wertheim, College of Medicine, Florida International University, Miami, Florida, USA.
- Herbert Wertheim College of Medicine, Institute of Neuroimmune Pharmacology, Miami, Florida International University, Florida, USA.
- Department of Chemistry, University of Miami, Coral Gables, Florida, USA.
ORCID-Profile: Nagesh Kolishetti, Shanta Dhar
Förderung
- Sylvester Comprehensive Cancer Center
- University of Miami
- Miller School of Medicine
- Florida Department of Health
- Department of Defence, United States
- National Institute of Health, United States
- Sylvester Comprehensive Cancer Center, University of Miami Health Systems
- Leonard M. Miller School of Medicine
Zitieren
APA
Sarkar, S., Greer, J., Marlowe, N. J., Medvid, A., Ivan, M. E., Kolishetti, N., & Dhar, S. (2024). Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1976
Vancouver
Sarkar S, Greer J, Marlowe NJ, Medvid A, Ivan ME, Kolishetti N, et al. Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1976
BibTeX
@article{Sarkar2024,
author = {Sarkar, Shrita and Greer, Jessica and Marlowe, Nathaniel J and Medvid, Angeline and Ivan, Michael E and Kolishetti, Nagesh and Dhar, Shanta},
title = {Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1976}
}
EUVIMED